Autolus Therapeutics PLC (AUTL)
4.00
-0.08
(-1.96%)
USD |
NASDAQ |
Apr 26, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Free Cash Flow (Quarterly): -26.31M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -26.31M |
| September 30, 2023 | -41.69M |
| June 30, 2023 | -42.54M |
| March 31, 2023 | -46.04M |
| December 31, 2022 | -15.20M |
| September 30, 2022 | -38.70M |
| June 30, 2022 | -33.45M |
| March 31, 2022 | -35.80M |
| December 31, 2021 | -10.74M |
| September 30, 2021 | -38.61M |
| Date | Value |
|---|---|
| June 30, 2021 | -38.12M |
| March 31, 2021 | -39.24M |
| December 31, 2020 | -33.20M |
| September 30, 2020 | -43.11M |
| June 30, 2020 | -29.46M |
| March 31, 2020 | -26.67M |
| December 31, 2019 | -35.18M |
| September 30, 2019 | -28.27M |
| June 30, 2019 | -22.86M |
| March 31, 2019 | -33.85M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-46.04M
Minimum
Mar 2023
-10.74M
Maximum
Dec 2021
-32.90M
Average
-35.18M
Median
Dec 2019
Free Cash Flow (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | -15.50M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.3701M |
| TC BioPharm (Holdings) PLC | -- |
| DBV Technologies SA | -14.04M |